SANUWAVE Health, Inc. Common Stock (SNWV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SANUWAVE Health, Inc. Common Stock (SNWV) has a cash flow conversion efficiency ratio of 0.216x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($397.00K) by net assets ($1.84 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SANUWAVE Health, Inc. Common Stock defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
SANUWAVE Health, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how SANUWAVE Health, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
SANUWAVE Health, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SANUWAVE Health, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
XXL ASA
OL:XXL
|
-0.085x |
|
BARK, Inc.
NYSE:BARK
|
0.021x |
|
Pembangunan Perumahan PT
JK:PTPP
|
-0.014x |
|
Unifi Inc
NYSE:UFI
|
0.035x |
|
Tridomain Performance Materials PT
JK:TDPM
|
0.076x |
|
Hainan Poly Pharm Co Ltd
SHE:300630
|
0.016x |
|
AEC SECURITIES
BK:BYD-R
|
N/A |
|
US Masters Residential Property Fund
AU:URF
|
-0.030x |
Annual Cash Flow Conversion Efficiency for SANUWAVE Health, Inc. Common Stock (2006–2025)
The table below shows the annual cash flow conversion efficiency of SANUWAVE Health, Inc. Common Stock from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see SANUWAVE Health, Inc. Common Stock (SNWV) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.62 Million | $3.88 Million | 2.394x | +1340.14% |
| 2024-12-31 | $-12.72 Million | $2.46 Million | -0.193x | -283.68% |
| 2023-12-31 | $-43.18 Million | $-4.54 Million | 0.105x | -74.90% |
| 2022-12-31 | $-41.01 Million | $-17.17 Million | 0.419x | +154.48% |
| 2021-12-31 | $-38.96 Million | $-6.41 Million | 0.165x | -82.25% |
| 2020-12-31 | $-13.72 Million | $-12.72 Million | 0.927x | +45.53% |
| 2019-12-31 | $-10.06 Million | $-6.41 Million | 0.637x | +170.14% |
| 2018-12-31 | $-15.36 Million | $-3.62 Million | 0.236x | +52.39% |
| 2017-12-31 | $-9.88 Million | $-1.53 Million | 0.155x | -66.57% |
| 2016-12-31 | $-6.91 Million | $-3.20 Million | 0.463x | -21.67% |
| 2015-12-31 | $-5.88 Million | $-3.47 Million | 0.591x | -86.27% |
| 2014-12-31 | $-1.55 Million | $-6.68 Million | 4.305x | +572.21% |
| 2013-12-31 | $-6.13 Million | $-3.92 Million | 0.640x | -2.69% |
| 2012-12-31 | $-6.52 Million | $-4.29 Million | 0.658x | -88.55% |
| 2011-12-31 | $-1.54 Million | $-8.83 Million | 5.748x | +930.25% |
| 2010-12-31 | $-10.52 Million | $-5.87 Million | 0.558x | -47.66% |
| 2009-12-31 | $-5.88 Million | $-6.27 Million | 1.066x | +85.53% |
| 2008-12-31 | $-72.97K | $-41.92K | 0.575x | +20.83% |
| 2007-12-31 | $-46.42K | $-22.07K | 0.475x | +25.28% |
| 2006-12-31 | $-10.73K | $-4.07K | 0.380x | -- |
About SANUWAVE Health, Inc. Common Stock
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses no… Read more